Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

45.97
-0.1400-0.30%
Post-market: 45.970.00000.00%16:10 EDT
Volume:1.22M
Turnover:56.18M
Market Cap:7.71B
PE:118.41
High:46.75
Open:46.75
Low:45.73
Close:46.11
52wk High:55.67
52wk Low:26.40
Shares:167.76M
Float Shares:155.00M
Volume Ratio:1.01
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3882
EPS(LYR):1.43
ROE:3.85%
ROA:4.20%
PB:4.26
PE(LYR):32.15

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Alkermes CMO Craig Hopkinson disposes 9,000 shares for $300,559.5

Reuters
·
May 02

Earning Preview: Alkermes PLC revenue expected to increase by 18.33% this quarter, institutions are broadly bullish

Earnings Agent
·
Apr 28

How Investors Are Reacting To Alkermes (ALKS) Strong Alixorexton Orexin-2 Data And Broader CNS Ambitions

Simply Wall St.
·
Apr 27

Alkermes schedules first-quarter results conference call and webcast

Reuters
·
Apr 22

Alkermes reports sustained Phase 2 alixorexton benefits in narcolepsy type 1 study

Reuters
·
Apr 16

Alkermes to Present Additional Data From Vibrance-1 Phase 2 Study of Alixorexton in Patients With Narcolepsy Type 1 at the American Academy of Neurology (Aan) 2026 Annual Meeting

THOMSON REUTERS
·
Apr 16

Alkermes announces publication of 56-week post hoc analysis of Lybalvi

TIPRANKS
·
Apr 14

Alkermes says 56-week analysis links Lybalvi to improved schizophrenia negative symptoms

Reuters
·
Apr 14

Findings From Long-Term Analysis of the Effects of Lybalvi® (Olanzapine and Samidorphan) on Negative Symptoms of Schizophrenia Published in the Journal of Clinical Psychiatry

THOMSON REUTERS
·
Apr 14

Alkermes Plc : Mizuho Raises Target Price to $53 From $45

THOMSON REUTERS
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Alkermes (ALKS)

TIPRANKS
·
Apr 10

Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

MT Newswires Live
·
Apr 09

BofA Adjusts Price Target on Alkermes Public to $36 From $34, Maintains Neutral Rating

MT Newswires Live
·
Apr 09

Alkermes EVP, CLO David Joseph Gaffin disposes of USD 70,309 in shares

Reuters
·
Apr 07

Stifel Nicolaus Keeps Their Buy Rating on Alkermes (ALKS)

TIPRANKS
·
Apr 04

Mizuho Securities Sticks to Their Buy Rating for Alkermes (ALKS)

TIPRANKS
·
Apr 02

Alkermes EVP R&D, CMO Craig Hopkinson disposes of shares worth $0.3 million

Reuters
·
Apr 02

TD Cowen Sticks to Their Buy Rating for Alkermes (ALKS)

TIPRANKS
·
Apr 02

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02